Transforming growth factor--activated kinase 1 (TAK1), an MAP3K, is a key player in processing a multitude of inflammatory stimuli. TAK1 autoactivation involves the interplay with TAK1-binding proteins (TAB), e.g. TAB1 and TAB2, and phosphorylation of several activation segment residues. However, the TAK1 autoactivation is not yet fully understood on the molecular level due to the static nature of available x-ray structural data and the complexity of cellular systems applied for investigation. Here, we established a bacterial expression system to generate recombinant mammalian TAK1 complexes. Coexpression of TAK1 and TAB1, but not TAB2, resulted in a functional and active TAK1-TAB1 complex capable of directly activating full-length heterotrimeric mammalian AMP-activated protein kinase (AMPK) in vitro. TAK1-dependent AMPK activation was mediated via hydrophobic residues of the AMPK kinase domain ␣G-helix as observed in vitro and in transfected cell culture. Co-immunoprecipitation of differently epitopetagged TAK1 from transfected cells and mutation of hydrophobic ␣G-helix residues in TAK1 point to an intermolecular mechanism of TAB1-induced TAK1 autoactivation, as TAK1 autophosphorylation of the activation segment was impaired in these mutants. TAB1 phosphorylation was enhanced in a subset of these mutants, indicating a critical role of ␣G-helix residues in this process. Analyses of phosphorylation site mutants of the activation segment indicate that autophosphorylation of Ser-192 precedes TAB1 phosphorylation and is followed by sequential phosphorylation of Thr-178, Thr-187, and finally Thr-184. Finally, we present a model for the chronological order of events governing TAB1-induced TAK1 autoactivation.Transforming growth factor--activated kinase 1 (TAK1) was first identified as an MAP3K 4 involved in transforming growth factor- and bone morphogenetic protein-mediated signaling (1). Because it transduces a multitude of extracellular stimuli, such as those from interleukin-1, tumor necrosis factor-␣, and lipopolysaccharides, the serine/threonine kinase TAK1 represents a key activator of pathways involving IB kinase, c-Jun NH 2 -terminal kinase (JNK), and p38 (2-9). Furthermore, a regulatory function of TAK1 has also been described in the Wnt signaling pathway (10, 11). TAK1 activity is regulated by association of TAK1-binding proteins, namely TAB1, TAB2, TAB3, and TAB4 (12-17). TAB1, a "pseudophosphatase" that shows close structural similarity with the Mg 2ϩ -or Mn 2ϩ -dependent protein phosphatase family member protein phosphatase 2C␣ (PP2C␣) (18), was originally found in a yeast two-hybrid screen as a protein, which directly triggers TAK1 activity (13). Both structural and functional studies revealed that an evolutionarily conserved motif in the carboxyl-terminal region of TAB1 (residues 480 -504) is sufficient to bind to the catalytic domain of TAK1. However, the presence of a slightly extended TAB1 carboxyl-terminal domain (residues 437-504) is indispensable for full activation of TAK1 in HeLa cells (19 -2...